VX-150 clinical trials
Also written VX-150.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2015
How each study uses VX-150 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- VX-150
- 6
Studies by the year they started
6 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2022 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses VX-150 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Microneurography Study of NaV1.8 Inhibition in Healthy AdultsCompletedPhase 1Vertex Pharmaceuticals IncorporatedNCT06420765Written as VX-150
- A Microneurography (MNG) Study of VX-150 in Healthy ParticipantsCompletedPhase 1Vertex Pharmaceuticals IncorporatedNCT05418712Written as VX-150
- A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following BunionectomyCompletedPhase 2Vertex Pharmaceuticals IncorporatedNCT03764072Written as VX-150
- A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber NeuropathyCompletedPhase 2Vertex Pharmaceuticals IncorporatedNCT03304522Written as VX-150
- A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following BunionectomyCompletedPhase 2Vertex Pharmaceuticals IncorporatedNCT03206749Written as VX-150
- A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the KneeCompletedPhase 2Vertex Pharmaceuticals IncorporatedNCT02660424Written as VX-150